<DOC>
	<DOC>NCT00622037</DOC>
	<brief_summary>To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.</brief_summary>
	<brief_title>Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Patient reported dry eye symptoms (episodic, annoying, activity limiting), SES OD. Physician assessment of mildmoderate dry eye Patient willing to instill drops QID and complete entire length of protocol. TBUT &lt; 10 seconds BCVA of 20/30 or better Current topical cyclosporine use (Restasis) Current Systane use Refractive surgery within the last 6 months Oral or topical corticosteroid use Severe dry eye patients by physician assessment current active Blepharitis Oral Doxycyclines use Oral Antihistamine use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>